Showing results (281-290 of 730) with videos related to
Sort By:
Pageof 73
World Neurosurgery|April 21, 2018
Early Prediction of Poor Outcome Despite Successful Recanalization After Endovascular Treatment for Anterior Large Vessel Occlusion StrokeHuaiming Wang, Meng Zhang, Yonggang Hao, et al.European Journal of Preventive Cardiology|July 18, 2018
Trends in age- and sex-specific prevalence and incidence of cardiovascular disease in Western AustraliaDanja Sarink, Lee Nedkoff, Tom Briffa, et al.BMJ Open|November 22, 2013
Cross vascular risk for first and recurrent hospitalised atherothrombosis determined retrospectively from linked dataTom G Briffa, Lee J Nedkoff, Matthew W Knuiman, et al.International Journal of Stroke : Official Journal of the International Stroke Society|October 2, 2018
Statistical analysis plan (SAP) for the Very Early Rehabilitation in Speech (VERSE) after stroke trial: an international 3-arm clinical trial to determine the effectiveness of early, intensive, prescribed, direct aphasia therapyErin Godecke, Tapan Rai, Dominique A Cadilhac, et al.Journal of Hypertension|December 11, 2002
Risk factors for non-haemorrhagic stroke in patients with coronary heart disease and the effect of lipid-modifying therapy with pravastatinMalcolm J West, Harvey D White, R John Simes, et al.The Journal of Clinical Endocrinology and Metabolism|March 11, 2020
U-Shaped Association of Plasma Testosterone, and no Association of Plasma Estradiol, with Incidence of Fractures in MenBu B Yeap, Helman Alfonso, S A Paul Chubb, et al.Stroke|July 3, 2010
Effect of clopidogrel on the rate and functional severity of stroke among high vascular risk patients: a prespecified substudy of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA) trialGraeme J Hankey, Werner Hacke, J Donald Easton, et al.International Journal of Cardiology|July 26, 2011
Downward trend in the prevalence of hospitalisation for atherothrombotic diseaseThomas G Briffa, Lee Nedkoff, Matthew Knuiman, et al.Stroke|February 12, 2013
Efficacy and safety of vorapaxar in patients with prior ischemic strokeDavid A Morrow, Mark J Alberts, Jay P Mohr, et al.Trials|June 16, 2022
Treatment fidelity monitoring, reporting and findings in a complex aphasia intervention trial: a substudy of the Very Early Rehabilitation in SpEech (VERSE) trialErin Godecke, Emily Brogan, Natalie Ciccone, et al.Pageof 73